CALR and myeloproliferative disorder: Interest in the release of endogenous CRT has gained momentum given its recent identified roles in immunogenic cell death of tumours39 and myeloproliferative neoplasms (MNPs)40 Numerous studies have investigated how CRT is released from cells during cell stress, pharmacological intervention or due to somatic mutations.41